Zacks via Yahoo
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates
Kronos Bio (KRON) delivered earnings and revenue surprises of -16.28% and 68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
3 hours ago